|
BioNTech
chi lob 7/4 Chi Lob 7/4, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/chi+lob+7/chi+lob+7+4/us12227565-2822-27-3 Average 90 stars, based on 1 article reviews
chi lob 7/4 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
CH Instruments
chi lob 7/4 Chi Lob 7/4, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/chi+lob+7/chi+lob+7+4/pm33504575-99-248-208 Average 90 stars, based on 1 article reviews
chi lob 7/4 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
CH Instruments
chi lob 4/7 ![]() Chi Lob 4/7, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/chi+lob+7/chi+lob+7+4/pmc07664461-30-2-2 Average 90 stars, based on 1 article reviews
chi lob 4/7 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
CH Instruments
agonistic cd40 antibody chi lob 7/4 ![]() Agonistic Cd40 Antibody Chi Lob 7/4, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/chi+lob+7/chimeric+anti+human+cd40+monoclonal+antibody+chi+220/pm30097487-42-1-16 Average 90 stars, based on 1 article reviews
agonistic cd40 antibody chi lob 7/4 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Article Title: Overcoming Tumor-Induced Immune Suppression: From Relieving Inhibition to Providing Costimulation with T Cell Agonists
doi: 10.1007/s40259-018-0277-2
Figure Lengend Snippet: Agonist antibody and Fc-ligands in clinical trials as mono and combination immunotherapies
Article Snippet: , ,
Techniques: Clinical Proteomics